Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( JPY)
Sales 2018 254 B
EBIT 2018 -
Net income 2018 39 954 M
Finance 2018 128 B
Yield 2018 1,79%
Sales 2019 269 B
EBIT 2019 -
Net income 2019 44 545 M
Finance 2019 139 B
Yield 2019 1,82%
P/E ratio 2018 34,34
P/E ratio 2019 29,81
EV / Sales2018 5,14x
EV / Sales2019 4,80x
Capitalization 1 431 B
More Financials
Company
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of pharmaceutical and diagnostic reagents focusing on prescription pharmaceuticals.Its products include respiratory, digestive, urinary, chemotherapy, hormone, vitamins, and metabolic drugs.The company was founded by Ichibei... 
More about the company
Surperformance© ratings of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More Ratings
Latest news on ONO PHARMACEUTICAL CO., LT
12/15 BRISTOL MYERS SQUIBB : Myers teams up with Opdivo maker Ono Pharmaceutical on ne..
12/14 ONO PHARMACEUTICAL : Enters into License Agreement with Bristol-Myers Squibb for..
12/12 ONO PHARMACEUTICAL : Enters into Collaboration Agreement with Cyclenium Pharma, ..
12/06 ONO PHARMACEUTICAL : CheckMate -078, a Pivotal, Multinational Phase 3 Opdivo (ni..
12/04 BRISTOL MYERS SQUIBB : Opdivo meets in Chinese Phase III for second-line NSCLC
12/01 ONO PHARMACEUTICAL : Announces Participation in United Nations Global Compact (1..
11/29 ONO PHARMACEUTICAL : European Medicines Agency Validates Bristol-Myers Squibb's ..
11/16 ONO PHARMACEUTICAL : Encouraging Response Observed with Opdivo (nivolumab) Plus ..
11/11 ONO PHARMACEUTICAL : Neurimmune Announces Collaboration With Ono Pharmaceutical ..
11/10 ONO PHARMACEUTICAL : Opdivo Plus Yervoy Combination Delivered Overall Survival B..
More news
Sector news : Generic Pharmaceuticals
02:24aDJSANOFI : Philippines Probes Vaccination Drive Amid Red Flags
12/17 TEVA PHARMACEUTICAL INDUSTRIES : Strike over Teva Pharm job cuts briefly shuts d..
12/16 PROCTER & GAMBLE : P&G appoints Peltz to board despite losing proxy battle
12/16 NELSON PELTZ : P&G appoints Peltz to board despite losing proxy battle
12/15 JAZZ PHARMACEUTICALS : Pennsylvania man admits to trading on tips about drug com..
More sector news : Generic Pharmaceuticals
News from SeekingAlpha
10/03 Ono Pharmaceutical Needs To Reinvest Its Windfall
09/29 YOUR DAILY PHARMA SCOOP : Axovant's Promised Upside, Gilead's Whistleblower Trou..
06/22 Only Bristol Bucks Big Pharma's Drive For External Reliance
06/02 3 THINGS IN BIOTECH YOU SHOULD LEARN : June 2, 2017
05/31 Array out-licenses binimetinib and encorafenib to Ono Pharma for Japan and So..
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Technical analysis trends ONO PHARMACEUTICAL CO., LT
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 2 900  JPY
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Gyo Sagara President & Representative Director
Shozo Matsuoka Executive Officer & Manager-Medical Affairs
Kazuhito Kawabata Director & Managing Executive Officer
Hiroshi Awata Director, EVP & General Manager-Development
Isao Ono Director & Managing Executive Officer
Sector and Competitors